New Drug Development: A Regulatory Overview (NEW DRUG DEVELOPMENT ( MATHIEU))

Mathieu, Mark P.

  • 3.38 out of 5 stars
    21 ratings by Goodreads
ISBN 10: 1882615859 ISBN 13: 9781882615858
Published by Barnett Educational Services / Chi, 2008
Used Hardcover

From Goodwill of Silicon Valley, SAN JOSE, CA, U.S.A. Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

AbeBooks Seller since June 28, 2024

This specific item is no longer available.

About this Item

Description:

Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Good condition! Any other included accessories are also in Good condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear. Seller Inventory # GWSVV.1882615859.G

  • 3.38 out of 5 stars
    21 ratings by Goodreads

Report this item

Synopsis:

Go inside the drug development and FDA regulatory process with today's most authoritative and popular reference on the topic. In its all-new 2008 edition, New Drug Development: A Regulatory Overview addresses the most cutting-edge developments redefining how new drugs are developed and regulated today, including:

* How the FDA Amendments Act of 2007 will affect everything from drug reviews to postmarketing requirements.

* How the CDER's efforts to integrate a culture of drug safety has affected the center's structure and its new drug review and approval processes.

* How CDER's much-anticipated January 2008 transition to the eCTD as the only valid esubmission format will affect the FDA's drug submission and review process.

* How the FDA and industry are already integrating pharmacogenomics, computer simulation, and other emerging technologies to inform key decisions.

* Which drug development strategies are fulfilling their promise and offering optimal returns for industry, given the explosion of accelerated development/approval programs and pilot programs to speed the drug development and review process.


Find out why New Drug Development is pharma/biotech's go-to resource for regulatory, clinical, project management, training, and other drug development disciplines navigating the FDA's drug development approval processes.

Review: This book provides the most comprehensive and up-to-date analysis of FDA's new drug development process available today. I recommend this well-written book for professionals engaged in the drug development and review process. --Biopharm Magazine

This book is superb! It is the single best source of information on the drug regulatory system. --Peter Barton Hutt, Covington & Burling

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: New Drug Development: A Regulatory Overview ...
Publisher: Barnett Educational Services / Chi
Publication Date: 2008
Binding: Hardcover
Condition: good

Top Search Results from the AbeBooks Marketplace